Is It Time to Buy Aurora Cannabis (TSX:ACB) or Tilray (NASDAQ:TLRY) Stock?

Aurora Cannabis (TSX:ACB) (NYSE:ACB) and Tilray (NASDAQ:TLRY) are two of the top global cannabis stocks. Is one a better bet after the recent pullback?

| More on:

Cannabis stocks have fallen from their recent highs, which has investors who missed the big rally wondering if this is the best opportunity they will have to add marijuana stocks to their portfolios.

Let’s take a look at Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Tilray (NASDAQ:TLRY) to see if one deserves to be on your buy list right now.

Aurora Cannabis

Aurora Cannabis traded for $15 per share in the middle of October, just before the opening of the Canadian recreational marijuana market. At the time of writing, investors can pick up the stock for $8. That puts the company’s market capitalization at close to $7.7 billion.

Management went on an aggressive buying spree this year, acquiring two large competitors. In January, Aurora Cannabis bought CanniMed for $1.1 billion. In July, the company took over MedReleaf for $2.5 billion. The deals launched Aurora Cannabis into the big leagues, placing it in the top ranks of the Canadian and global cannabis sector with rivals Canopy Growth and Tilray.

Aurora’s presence in Alberta, Ontario, and Quebec puts it in a good position to serve the Canadian medical and recreational pot markets. It has also established subsidiaries or partnerships in key global markets, including Europe, Australia and South America.

To date, Aurora Cannabis has not announced a partnership with a major beverage company. A deal of some sort is expected, as Canopy Growth and HEXO already have a head start on the development of cannabis-infused drinks with their respective beer partners, Constellation Brands and Molson Coors Canada.

Aurora Cannabis could decide to acquire HEXO, which would solve the problem, while boosting the presence in Quebec.

Tilray

Tilray made a big splash in the headlines when it announced that it had received approval to import medical marijuana into the United States for research purposes. The news signalled a small step in the process of potentially getting medical marijuana sales legalized at the federal level in the United States.

Investors shouldn’t hold their breath for a quick decision, but positioning early for the opportunity is worth considering. Tilray is widely viewed as the company that would become an early leader if the U.S. opens up its medical marijuana market across the country.

The company is well established in Europe. Tilray also has operations in Australia, South Africa, and South America.

The stock soared from US$22 per share in July to a closing high above US$214 per share in September, but has pulled back in the past two months and currently trades for close to US$107 per share at writing. This gives it a market capitalization of about US$10 billion, or $13 billion in Canadian dollars.

Is one a better bet?

Aurora Cannabis and Tilray are both expected to emerge as long-term leaders in the growing global cannabis industry.

Any news of a beverage deal could send Aurora’s stock higher. At the same time, another pricy acquisition might put pressure on the share price.

Tilray is the largest player in the sector by market capitalization and appears to be primarily focused on the global medical marijuana opportunities. If you want to own the market leader, Tilray might be a better bet.

Despite the pullbacks, both stocks appear very expensive, so any new position should be kept small. More volatility is likely on the way and further downside is very possible given the negative sentiment in the broader equity markets.

If you think the upside in pot stocks is limited, there are other disruptor plays to consider today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Investing

Nuclear power station cooling tower
Metals and Mining Stocks

If You’d Invested $1,000 in Cameco Stock 5 Years Ago, This Is How Much You’d Have Now

Cameco (TSX:CCO) stock still looks undervalued, despite a 258% rally. Can the uranium miner deliver more capital gains to shareholders?

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Dividend Stocks

TFSA Magic: Earn Enormous Passive Income That the CRA Can’t Touch

If you're seeking out passive income, with zero taxes involved, then get on board with a TFSA and this portfolio…

Read more »

Man with no money. Businessman holding empty wallet
Dividend Stocks

2 Stocks Under $50 New Investors Can Confidently Buy

There are some great stocks under $50 that every investor needs to know about. Here’s a look at two great…

Read more »

potted green plant grows up in arrow shape
Stocks for Beginners

3 Growth Stocks I’m Buying in April

These three growth stocks are up in the last year, and that is likely to continue on as we keep…

Read more »

clock time
Tech Stocks

Long-Term Investing: 3 Top Canadian Stocks You Can Buy for Under $20 a Share

These three under-$20 stocks offer excellent buying opportunities for long-term investors.

Read more »

Arrowings ascending on a chalkboard
Energy Stocks

Beat the TSX With This Cash-Gushing Dividend Stock

Canadian Natural Resources stock is well set up to beat the TSX as it continues to generate strong cash flows…

Read more »

think thought consider
Dividend Stocks

Down 10.88%: Is ATD Stock a Good Buy After Earnings?

Alimentation Couche-Tard (TSX:ATD) stock might not be the easy buy-case it once was. Here’s a look at what happened.

Read more »

money cash dividends
Dividend Stocks

TFSA Dividend Stocks: Earn $1,200/Year Tax-Free

Canadian stocks like Fortis are a must-have in your portfolio to earn tax-free yields for decades.

Read more »